The Directorate General of Drug Administration under the Ministry of Health & Family Welfare, Government of the People's Republic of Bangladesh is the Drug Regulatory Authority of the country. This Directorate supervises and implements all prevailing Drug Regulations in the country and regulates all activities related to import, procurement of raw and packing materials, production and import of finished drugs, export, sale, pricing, etc. of all kinds of medicine including those of Ayurvedic, Unani, Herbal and Homoeopathic systems. At present, there are 271 Allopathic, 205 Ayurvedic, 271 Unani, 32 Herbal, and 79 Homeopathic drug manufacturing companies in the country. The Directorate General of Drug Administration monitors and regulates all the activities of these 858 companies. The chief of the Directorate, designated as the Director-General, is also empowered by the Govt. to act as the Licensing Authority (LA) of drugs for the purpose of issuing licenses to manufacture, store, sell, import, and export drugs and medicines. At present, there are 55 district offices of the Directorate in the country. All officers of the Directorate function as "Drug Inspector" pursuant to the Drug Laws and assist the Licensing Authority for properly discharging his responsibilities. Besides, a number of Committees, such as the Drug Control Committee (DCC), Standing Committee for procurement and import of raw materials and finished drugs, Pricing Committee, and a number of other relevant committees, which comprise of experts, are there to advise the Licensing Authority and to recommend to him matters related to drugs and medicines.

To safeguard the health of humans and animals by ensuring the medicines and medical devices meet applicable standards of safety, quality, and efficacy.

To ensure the safety and security of the supply chain for medicines and medical devices.

To ensure availability including accessibility and affordability and rational use of essential medicines.

To foster a regulatory environment that supports research and innovation and thereby ensures moving towards global standards for quality products.